The Arena
A drugmaker with a $15 million-a-day incentive to move faster just bought into frontier models, and Google published the paper that shows where the self-improvement loop actually lives. Novo Nordisk will test Anthropic's models and its Claude Science workbench inside its own research and development workflows.
The Arena
Morning on three fronts: a Chinese super-app prices its science arm separately from the ads business, a laptop finally gets enough memory and watts to argue about 300-billion-parameter models, and China starts asking what school is for when translation is free. ByteDance has closed a $290 million round for Anew Labs, the Shanghai-based AI drug discovery unit it spun out of the group, at a $1.5 billion valuation, according to Reuters, which spoke to two people with knowledge of the matter.
The Arena
Monday afternoon's money went into the least glamorous part of the AI stack — the part with a regulator attached. Stockholm's Tandem Health landed Europe's biggest clinical-AI round to date, Waymo opened its doors in Las Vegas, and Akuity made the case that agents need an identity before they get a production deploy. Tandem Health raised a $100M Series B led by the Scaleup Europe Fund, the €5 billion vehicle the European Commission put EQT in charge of this year.
The Arena
China's AI-for-drug-discovery crowd spent Sunday at the Pujiang Innovation Forum arguing about the thing benchmarks don't measure — what happens after the model proposes. And the country's biggest banks are quietly building a lending product around the same question: is AI usage real enough to lend against? "The more you generate, the more you fail." That was Ding Sheng, founding dean of Tsinghua's school of pharmaceutical sciences, at the forum's Future Medicine track on September 13, and the…
The Frontier
Apple's ML research group has had a quietly productive week, and today it landed three papers at once: a protein-design model trained straight in the raw data space, a benchmark that grades video captions with quizzes instead of reference text, and a sign-language translator that finally pays attention to what was said two sentences ago.
The Frontier
Two stories about AI leaving the chat window: one where a generative model designed a delivery vehicle that outperforms the industry's standard carriers in animals, and one where ordinary investors are handing their brokerage accounts to agents and hoping for the best. Researchers at Helmholtz Munich and the Technical University of Munich have built an RNA delivery vehicle from scratch — and its scaffold was designed by generative AI, not borrowed from nature.
The Frontier
Two medical AI stories landed within hours of each other, and read together they trace the field's central argument: the machines keep doing things nobody has done before, while the people who measure them still can't agree on what a result actually proves. A Chinese military hospital has completed the world's first congenital heart defect repair guided by an autonomous ultrasound robot.
The Guardrails
Two moves this afternoon define where AI is actually being trusted: OpenAI wired ChatGPT straight into the electronic health record that most US hospitals run on, and the EU finalised a rulebook that treats a chatbot as infrastructure subject to public-safety law. Different rooms, same question — who carries the risk when the model misreads the record. OpenAI says ChatGPT for Healthcare can now read Epic patient records, and the ceiling matters more than the feature.
The Everyday
One in three US adults has used an AI chatbot for health advice, Pew finds — and most rate the answers as helpful. A Pew Research Center survey of 3,488 US adults fielded June 22–28 found 34% have used chatbots for at least one health reason: 28% for fast answers, 25% to figure out what's causing symptoms, 22% because it's free or nearly free. Adoption runs far ahead of the average among Asian Americans (56%), adults under 30 (44%) and upper-income users (48%).
The Frontier
Alibaba's research arm, DAMO Academy, has published a medical-imaging AI model in Nature Medicine that reads the contrast-enhanced CT scans radiologists already order and flags liver cancers the human eye missed. In a two-month deployment inside a routine clinical workflow, the model helped clinicians find 15 malignant tumors — most of them around a centimeter in diameter — that had been overlooked, and changed treatment plans for patients as a result. We should be careful about what this is…
The Guardrails
The FDA is weighing whether generative AI health products should pass "competency-based" exams — modeled on how human clinicians are trained, tested, and credentialed — before they can be marketed as medical devices. The idea sits in a discussion draft the agency's device center published this week, and it is explicitly a question, not a rule: the FDA says the paper is "for discussion purposes only," with public comments open until October 19. The proposed framework would test the final…
The Guardrails
AI voice cloning is colliding with performers' rights again — this time over a drug ad tied to a popular Chinese series. A working voice actor says a hit Chinese drama used an AI-cloned version of his voice in a drug advertisement and a side-story, without ever asking him. Ma Zhengyang (马正阳), a professional voice actor, posted a statement on Weibo saying he had never authorized any form of use of his voice and demanding the infringing party stop.